Latest Pharmacovigilance Podcast Episodes

Drug Safety Matters artwork

#8 How do we change behaviour around antimicrobial resistance?

Drug Safety Matters - April 27, 2021 06:00 - 47 minutes
Antimicrobial resistance (AMR) is not only a biological issue, but a complex social problem. As a consequence, changing the way patients, healthcare professionals and policymakers think about antibiotics will require input from both the natural and social sciences. In March 2021, the Uppsala Hea...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Into the infodemic

Drug Safety Matters - March 26, 2021 15:00 - 27 minutes
As the COVID-19 pandemic spread around the world, so did waves of viral misinformation. For pharmacovigilance manager Marco Tuccori, fighting the “infodemic” is a massive, but necessary, battle. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s ...

Drug Safety Matters artwork

#7 The challenge of rare diseases – Christina Ström Möller

Drug Safety Matters - February 26, 2021 08:00 - 24 minutes
By definition, a rare disease is one that only affects a handful of people in the world. But with more than 300 million people collectively affected by these conditions and only few approved treatments available, rare diseases constitute a major unmet medical need. Christina Ström Möller from Sw...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research

Drug Safety Matters - February 03, 2021 12:00 - 12 minutes
As the cradle of modern humanity, the African continent is home to populations with high levels of genetic diversity. But while this diversity has implications for the safety and efficacy of many drugs, African patients remain underrepresented in drug studies. In fact, while more than 400 medici...

Drug Safety Matters artwork

#6 Intuition in pharmacovigilance – Eugene van Puijenbroek

Drug Safety Matters - December 17, 2020 08:00 - 25 minutes
In the age of evidence-based medicine, we may be tempted to dismiss intuition – the quick and automatic thought process we call “sixth sense” or “gut feeling” – as unscientific guesswork. But in clinical decision-making, intuitive reasoning is just as important as the slower and more analytical ...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Patient's advocate

Drug Safety Matters - November 26, 2020 08:00 - 9 minutes
In November 2020, longstanding UMC director Marie Lindquist began her well-earned retirement, leaving the reins of the organisation to her successor Hervé Le Louët. As she prepared to open a new chapter in her life, she sat down with Uppsala Reports to take a fond look back at an extraordinary c...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Vaccination errors risk harm and damage trust

Drug Safety Matters - October 23, 2020 09:00 - 9 minutes
Medication errors with vaccines can harm individual patients, but when they also undermine trust in public health programmes, serious problems can ripple across entire communities – as the Samoan healthcare crisis of 2018 dramatically showed. The Institute for Safe Medication Practices offers st...

Drug Safety Matters artwork

#5 Restoring invisible and abandoned trials – Peter Doshi

Drug Safety Matters - September 30, 2020 15:00 - 34 minutes
Clinical trials are the “gold standard” of evidence-based medicine – the best way we have to test whether a drug is safe and effective before it enters the market. But if trial data is poorly reported or – even worse – left unpublished, how are we supposed to determine the true value of a medica...

Drug Safety Matters artwork

#4 Communicating science through film – Matthew Barwick

Drug Safety Matters - August 27, 2020 12:00 - 28 minutes
Communication and public outreach are an important part of a scientist’s job. But researchers often find it daunting to translate their expert knowledge for a lay audience. In this episode, UMC’s video producer Matthew Barwick shares a report from the Global Science Film Festival 2019, including...

Drug Safety Matters artwork

#4 Communicating science through film – Matthew Barwick

Drug Safety Matters - August 27, 2020 12:00 - 28 minutes
Communication and public outreach are an important part of a scientist’s job. But researchers often find it daunting to translate their expert knowledge for a lay audience. In this episode, UMC’s video producer Matthew Barwick shares a report from the Global Science Film Festival 2019, including...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Found in space

Drug Safety Matters - August 06, 2020 10:00 - 22 minutes
When reporting adverse reactions to drugs, people can choose from a plethora of different terms to describe their experience. But that makes it difficult and time-consuming for analysts to tell how similar two case safety reports are. A new method developed by UMC data scientist Lucie Gattepaill...

Drug Safety Matters artwork

Uppsala Reports Long Reads – 10 critical steps for patient safety

Drug Safety Matters - July 16, 2020 10:00 - 17 minutes
How do we minimise the harm caused to patients by medicines and medical devices? In October 2019, a diverse, multi-stakeholder group met in Erice, Italy and drew up a 10-point plan for improving patient safety worldwide. This episode is part of the Uppsala Reports Long Reads series – the most t...

Drug Safety Matters artwork

#3 Navigating the plant names jungle – Bob Allkin

Drug Safety Matters - June 25, 2020 08:00 - 40 minutes
Herbal substances can be found in a number of pharmaceutical drugs, cosmetics and food supplements – so it's not surprising that using plant names inconsistently can have serious health consequences. But with so much confusion around medicinal plant names, it’s easy to get it wrong. Bob Allkin f...

Drug Safety Matters artwork

#2 Why we should listen to patients – Linda Härmark

Drug Safety Matters - May 20, 2020 15:00 - 28 minutes
As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Li...

Drug Safety Matters artwork

#2 Why we should listen to patients – Linda Härmark

Drug Safety Matters - May 20, 2020 15:00 - 28 minutes
As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Li...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Philosophy of science meets patient safety

Drug Safety Matters - May 13, 2020 07:00 - 12 minutes
Most of us want healthcare to be both patient-centric and evidence-based. But are those two goals compatible? Can we tailor healthcare to our unique circumstances­, while relying on the average statistical measurements that scientific evidence is based on? Emerging ideas in the philosophy of sci...

Drug Safety Matters artwork

Uppsala Reports Long Reads – Ending the pregnant pause

Drug Safety Matters - April 24, 2020 08:00 - 25 minutes
Most women are prescribed some form of medication during their pregnancy. Yet we know very little about the safety of those medicines when they’re used during pregnancy or breastfeeding. New collaborative efforts are now underway to plug that knowledge gap. This episode is part of the Uppsala R...

Drug Safety Matters artwork

#1 Fighting the fakes – Aline Plançon

Drug Safety Matters - January 27, 2020 10:00 - 28 minutes
Fake medicines claim at least 200,000 lives every year, with the World Health Organization estimating that 1 in 10 medicines worldwide is now substandard or falsified. But with the market in illicit drugs worth up to $200 billion a year, and traffickers more likely to face a fine than jail time ...

Drug Safety Matters artwork

#1 Fighting the Fakes – Aline Plançon

Drug Safety Matters - January 27, 2020 10:00 - 28 minutes
Fake medicines claim at least 200,000 lives every year, with the World Health Organization estimating that 1 in 10 medicines worldwide is now substandard or falsified. But with the market in illicit drugs worth up to $200 billion a year, and traffickers more likely to face a fine than jail time ...

Related Pharmacovigilance Topics